相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of neratinib (N), pembrolizumab (P), everolimus (E), and nivolumab (V) in patients (pts) with fibrolamellar carcinoma (FLC).
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Patient characteristics and survival outcomes in gastrointestinal cancers harboring RNF43 mutations or RSPO3 fusions: a retrospective analysis.
Paul Sackstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
Carina Heydt et al.
BMC MEDICAL GENOMICS (2021)
Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma
Kenta Kawasaki et al.
GASTROENTEROLOGY (2020)
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al.
NATURE (2020)
Patterns of somatic structural variation in human cancer genomes
Yilong Li et al.
NATURE (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer
Ling-Shih Chang et al.
ELIFE (2020)
CRISPR off-target detection with DISCOVER-seq
Beeke Wienert et al.
NATURE PROTOCOLS (2020)
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Erwei Zuo et al.
NATURE PROTOCOLS (2020)
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden
Ryma Benayed et al.
CLINICAL CANCER RESEARCH (2019)
Optimized base editors enable efficient editing in cells, organoids and mice
Maria Paz Zafra et al.
NATURE BIOTECHNOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (vol 174, pg 758, 2018)
David A. Quigley et al.
CELL (2018)
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis
John Hilkens et al.
GUT (2017)
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Julie W. Reeser et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Alice T. Shaw et al.
LANCET ONCOLOGY (2017)
GuideScan software for improved single and paired CRISPR guide RNA design
Alexendar R. Perez et al.
NATURE BIOTECHNOLOGY (2017)
DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma
Edward R. Kastenhuber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine
Teng Han et al.
NATURE COMMUNICATIONS (2017)
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
Peter J. Cook et al.
NATURE COMMUNICATIONS (2017)
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Yu Liu et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
A versatile reporter system for CRISPR-mediated chromosomal rearrangements
Yingxiang Li et al.
GENOME BIOLOGY (2015)
Receptor-type protein tyrosine phosphatase. directly dephosphorylates CD133 and regulates downstream AKT activation
O. Shimozato et al.
ONCOGENE (2015)
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo et al.
NATURE (2014)
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Wen Xue et al.
NATURE (2014)
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Samuel H. Sternberg et al.
NATURE (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
Joshua N. Honeyman et al.
SCIENCE (2014)
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system
R. Torres et al.
NATURE COMMUNICATIONS (2014)
Targeted genomic rearrangements using CRISPR/Cas technology
Peter S. Choi et al.
NATURE COMMUNICATIONS (2014)
Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology
Rafael B. Blasco et al.
CELL REPORTS (2014)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Cancer translocations in human cells induced by zinc finger and TALE nucleases
Marion Piganeau et al.
GENOME RESEARCH (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Mouse Model for ROS1-Rearranged Lung Cancer
Yasuhito Arai et al.
PLOS ONE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Expression of BCR/ABL p210 from a Knockin Allele Enhances Bone Marrow Engraftment without Inducing Neoplasia
Samantha B. Foley et al.
CELL REPORTS (2013)
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
Young Seok Ju et al.
GENOME RESEARCH (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mouse models of human AML accurately predict chemotherapy response
Johannes Zuber et al.
GENES & DEVELOPMENT (2009)
A mouse model for EML4-ALK-positive lung cancer
Manabu Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Discovery of the Philadelphia chromosome: a personal perspective
Peter C. Nowell
JOURNAL OF CLINICAL INVESTIGATION (2007)
Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development
Norman E. Sharpless et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis
LF Drynan et al.
EMBO JOURNAL (2005)
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function:: implications for alveolar rhabdomyosarcoma cell of origin
C Keller et al.
GENES & DEVELOPMENT (2004)
Engineering de novo reciprocal chromosomal translocations associated with MII to replicate primary events of human cancer
A Forster et al.
CANCER CELL (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice
K Lange et al.
ONCOGENE (2003)
Engineering chromosomal rearrangements in mice
YJ Yu et al.
NATURE REVIEWS GENETICS (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Two critical hits for promyelocytic leukemia
LZ He et al.
MOLECULAR CELL (2000)
Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse
F Buchholz et al.
EMBO REPORTS (2000)
Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development
EC Collins et al.
EMBO REPORTS (2000)
Frequent chromosomal translocations induced by DNA double-strand breaks
C Richardson et al.
NATURE (2000)